Effect of deletion of epidermal growth factor-like domain on plasma clearance of pro-urokinase

[1]  B. Smedsrød,et al.  Uptake and Degradation of Tissue Plasminogen Activator in Rat Liver , 1988, Thrombosis and Haemostasis.

[2]  B. Reavy,et al.  A tissue-type plasminogen activator mutant with prolonged clearance in vivo. Effect of removal of the growth factor domain. , 1988, The Journal of biological chemistry.

[3]  G. Larsen,et al.  Pharmacokinetics and thrombolytic properties of deletion mutants of human tissue-type plasminogen activator in rabbits. , 1988, Blood.

[4]  E. Appella,et al.  The receptor-binding sequence of urokinase. A biological function for the growth-factor module of proteases. , 1987, The Journal of biological chemistry.

[5]  E. Appella,et al.  The Receptor-Binding Sequence of Urokinase , 1987 .

[6]  E. Appella,et al.  Autocrine saturation of pro-urokinase receptors on human A431 cells , 1986, Cell.

[7]  T. Suyama,et al.  Establishment of passive hemagglutination assay (PHA) system for anti-HBc in plasma. , 1986, The Tohoku journal of experimental medicine.

[8]  J. Emeis,et al.  Hepatic Clearance of Tissue-Type Plasminogen Activator in Rats , 1985, Thrombosis and Haemostasis.

[9]  T. Suyama,et al.  Proteolytic cleavage of single-chain pro-urokinase induces conformational change which follows activation of the zymogen and reduction of its high affinity for fibrin. , 1985, The Journal of biological chemistry.

[10]  H. Berger,et al.  Catabolism of human tissue plasminogen activator in mice. , 1985, Blood.

[11]  D. Belin,et al.  A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase , 1985, The Journal of cell biology.

[12]  P. Wallén,et al.  In vivo metabolism of human tissue-type plasminogen activator. , 2009, Scandinavian journal of haematology.

[13]  S. Husain,et al.  Purification and partial characterization of a single-chain high-molecular-weight form of urokinase from human urine. , 1983, Archives of biochemistry and biophysics.

[14]  J. Zeuthen,et al.  Purification of zymogen to plasminogen activator from human glioblastoma cells by affinity chromatography with monoclonal antibody. , 1982, Biochemistry.

[15]  L. Ossowski,et al.  A proenzyme form of human urokinase. , 1982, The Journal of biological chemistry.

[16]  D. Rijken,et al.  Immunological characterization of plasminogen activator activities in human tissues and body fluids. , 1981, The Journal of laboratory and clinical medicine.

[17]  G. Vogel.  Clinical Use of Streptokinase , 1978 .

[18]  T. Kosugi,et al.  Urokinase inactivation rate in the rabbit: effect of circulatory isolation of the liver, spleen and kidneys. , 1978, Haemostasis.

[19]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[20]  K. Robbins,et al.  The peptide chains of human plasmin. Mechanism of activation of human plasminogen to plasmin. , 1967, The Journal of biological chemistry.